The World Health Organization is assisting Nigeria after confirming the nation’s first case of Ebola Bundibugyo virus disease in a female patient who recently traveled from Uganda. The infected individual arrived in the country and began exhibiting symptoms four days later on 7 October. She subsequently sought medical attention at a private healthcare facility in the capital city of Abuja on 11 October, and laboratory testing officially confirmed the diagnosis on 20 October. The patient is currently kept in isolation and receives medical treatment while investigations proceed to establish the probable source of her infection and trace her complete travel and exposure history.
Response and Contact Tracing Efforts
Nigerian health authorities have successfully identified 44 contacts who are currently undergoing close monitoring as response teams intensify efforts to locate other individuals who may have been exposed. Infection prevention and control protocols are being significantly strengthened at the private medical facility where the patient originally sought care. The Nigeria Centre for Disease Control and Prevention has activated its incident management system to properly coordinate the overall response. The UN agency emphasized that prompt identification of cases, timely follow-up of all contacts, and effective infection prevention remain vital for containing the virus.
Regional Context and WHO Guidelines
Nigeria marks the fifth country to identify Ebola Bundibugyo virus disease since an outbreak was declared in the Democratic Republic of the Congo in mid-May. Congolese health authorities recorded more than 9,500 cases and over 4,200 deaths as of 18 October, with no vaccine currently available to treat the virus. Uganda previously faced an outbreak that was declared over in late August, alongside nine reported cases in Kenya and one in the Netherlands linked to the DRC. The WHO and its partners are closely collaborating with Nigerian health authorities to bolster control measures, provide essential supplies including personal protective equipment for health workers, maintain robust disease surveillance, and ensure laboratories can safely test suspected cases without recommending any travel or trade restrictions.
Source: Cosmo News Desk
